BigCommerce Announces Second Quarter Financial Results
Second Quarter Total Revenue of $36.3 Million, YoY of 33%Total ARR of $151.8 Million, YoY of 32%AUSTIN, Texas, Sept. 09, […]
NXP Semiconductors Announces Redemption of 4.125% Senior Notes Due 2021 and 4.625% Senior Notes Due 2022
EINDHOVEN, The Netherlands, Sept. 09, 2020 (GLOBE NEWSWIRE) — NXP Semiconductors N.V. (NASDAQ: NXPI) through its subsidiaries NXP B.V. and […]
Zscaler Reports Fourth Quarter and Fiscal 2020 Financial Results
Fourth Quarter HighlightsRevenue grows 46% year-over-year to $125.9 millionCalculated billings grow 55% year-over-year to $194.9 millionDeferred revenue grows 47% year-over-year […]
Concrete Pumping Holdings Reports Robust Third Quarter Fiscal Year 2020 Results
DENVER, Sept. 09, 2020 (GLOBE NEWSWIRE) — Concrete Pumping Holdings, Inc. (Nasdaq: BBCP) (the “Company” or “CPH”), a leading provider […]
nCino Reports Record Second Quarter Fiscal 2021 Financial Results
Total Revenues Increased 52% Year-over-YearSubscription Revenues Increased 70% Year-over-YearWILMINGTON, N.C., Sept. 09, 2020 (GLOBE NEWSWIRE) — nCino, Inc. (NASDAQ: NCNO), […]
Zscaler Releases New Data Protection Innovations in Zscaler Zero Trust Exchange
SAN JOSE, Calif., Sept. 09, 2020 (GLOBE NEWSWIRE) — Zscaler, Inc., the leader in cloud security, today announced new data […]
Intra-Cellular Therapies Announces Proposed Public Offering of Common Stock
NEW YORK, Sept. 09, 2020 (GLOBE NEWSWIRE) — Intra-Cellular Therapies, Inc. (Nasdaq:ITCI), a biopharmaceutical company, today announced that it has […]
Kiniksa Pharmaceuticals to Present at the Morgan Stanley 18th Annual Global Healthcare Conference
HAMILTON, Bermuda , Sept. 09, 2020 (GLOBE NEWSWIRE) — Kiniksa Pharmaceuticals, Ltd. (Nasdaq: KNSA) announced today that it will present […]
Paratek Pharmaceuticals to Present at H.C. Wainwright 22nd Annual Global Investment Conference
BOSTON, Sept. 09, 2020 (GLOBE NEWSWIRE) — Paratek Pharmaceuticals, Inc. (Nasdaq: PRTK), a commercial-stage biopharmaceutical company focused on the development […]
TSX News -
Trillium Announces Proposed Public Offering of Common Shares
CAMBRIDGE, Mass., Sept. 09, 2020 (GLOBE NEWSWIRE) — Trillium Therapeutics Inc. (“Trillium” or the “Company”) (NASDAQ/TSX: TRIL), a clinical stage […]
